Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

445 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2).
Eriksson BI, Turpie AG, Lassen MR, Prins MH, Agnelli G, Kälebo P, Wetherill G, Wilpshaar JW, Meems L; ONYX-2 STUDY GROUP. Eriksson BI, et al. Among authors: prins mh. J Thromb Haemost. 2010 Apr;8(4):714-21. doi: 10.1111/j.1538-7836.2010.03748.x. Epub 2010 Jan 17. J Thromb Haemost. 2010. PMID: 20088935 Free article. Clinical Trial.
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial.
Piccioli A, Lensing AW, Prins MH, Falanga A, Scannapieco GL, Ieran M, Cigolini M, Ambrosio GB, Monreal M, Girolami A, Prandoni P; SOMIT Investigators Group. Piccioli A, et al. Among authors: prins mh. J Thromb Haemost. 2004 Jun;2(6):884-9. doi: 10.1111/j.1538-7836.2004.00720.x. J Thromb Haemost. 2004. PMID: 15140122 Free article. Clinical Trial.
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW; ARTEMIS Investigators. Cohen AT, et al. Among authors: prins mh. BMJ. 2006 Feb 11;332(7537):325-9. doi: 10.1136/bmj.38733.466748.7C. Epub 2006 Jan 26. BMJ. 2006. PMID: 16439370 Free PMC article. Clinical Trial.
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis.
Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Sørensen H, Pesavento R, Iotti M, Casiglia E, Iliceto S, Pagnan A, Lensing AW. Prandoni P, et al. Among authors: prins mh. J Thromb Haemost. 2006 Sep;4(9):1891-6. doi: 10.1111/j.1538-7836.2006.02058.x. J Thromb Haemost. 2006. PMID: 16961597 Free article.
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Davidson BL, Büller HR, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, Segers AE, Lensing AW; Matisse Investigators. Davidson BL, et al. Among authors: prins mh. J Thromb Haemost. 2007 Jun;5(6):1191-4. doi: 10.1111/j.1538-7836.2007.02565.x. J Thromb Haemost. 2007. PMID: 17403087 Free article. Clinical Trial.
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery.
Eriksson BI, Turpie AG, Lassen MR, Prins MH, Agnelli G, Kälebo P, Gaillard ML, Meems L; ONYX study group. Eriksson BI, et al. Among authors: prins mh. J Thromb Haemost. 2007 Aug;5(8):1660-5. doi: 10.1111/j.1538-7836.2007.02644.x. J Thromb Haemost. 2007. PMID: 17663737 Free article. Clinical Trial.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Büller HR; RE-NOVATE Study Group. Eriksson BI, et al. Among authors: prins mh. Lancet. 2007 Sep 15;370(9591):949-56. doi: 10.1016/S0140-6736(07)61445-7. Lancet. 2007. PMID: 17869635 Clinical Trial.
445 results